Target intelligence / Profile preview

Ribosomal protein S20 pseudogene 15 (RPS20P15)

Target: RPS20P15
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein S20 pseudogene 15 is a noncoding (pseudogene) sequence in the human genome closely related to the gene encoding ribosomal protein S20. It does not encode a functional protein and is not directly involved in cellular processes or disease. Pseudogenes are generally considered genetic relics, derived from duplication or mutation of functional genes. RPS20P15 has no recognized biological, clinical, or pharmacological function.

Other names: RPS20P15RPS20_5_351Ribosomal Protein S20 (RPS20) Pseudogene

Mechanism of action

None. Since it is not a functional protein-coding gene, mechanisms of action for therapeutic agents do not apply

Biological functions

None (pseudogenes generally do not have direct biological functions; their function is non-coding/vestigial)

Disease associations

None directly attributed; functional RPS20 gene mutations are associated with Diamond-Blackfan anemia and familial colorectal cancer type X, but the pseudogene itself has not been attributed with disease roles. There is no evidence suggesting RPS20P15 plays a role in disease.

Safety considerations

None. Pseudogene status means it is not a therapeutic target; there are no known safety concerns or therapeutic challenges

Interacting drugs

None

Biomarkers

None attributed to RPS20P15. Functional ribosomal proteins can serve as biomarkers, but not this pseudogene

Beyond the preview

Go deeper on Ribosomal protein S20 pseudogene 15 (RPS20P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S20 pseudogene 15 (RPS20P15).

Explore the full profile